Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 15 de 15
Filtre
1.
Indian Heart J ; 2022 Jun; 74(3): 194-200
Article | IMSEAR | ID: sea-220894

Résumé

Aims: Sudden cardiac death (SCD) continues to be a devastating complication amongst survivors of myocardial infarction (MI). Mortality is high in the initial months after MI. The aims of the INSPIRE-ELR study were to assess the proportion of patients with significant arrhythmias early after MI and the association with mortality during 12 months of follow-up. Methods: The study included 249 patients within 14 days after MI with left ventricular ejection fraction (LVEF) _x0001_35% at discharge in 11 hospitals in India. Patients received a wearable external loop recorder (ELR) 5 ± 3 days after MI to monitor arrhythmias for 7 days. Results: Patients were predominantly male (86%) with a mean age of 56 ± 12 years. In 82%, reperfusion had been done and all received standard of care cardiovascular medications at discharge. LVEF was 32.2 ± 3.9%, measured 5.1 ± 3.0 days after MI. Of the 233 patients who completed monitoring (7.1 ± 1.5 days), 81 (35%) experienced significant arrhythmias, including Ventricular Tachycardia/Fibrillation (VT/ VF): 10 (4.3%); frequent Premature Ventricular Contractions (PVCs): 65 (28%); Atrial Fibrillation (AF): 8 (3.4%); chronic atrial flutter: 4 (1.7%); 2nd or 3rd degree Atrioventricular (AV) block: 4 (1.7%); and symptomatic bradycardia: 8 (3.4%). In total, 26 patients died. Mortality was higher in patients with clinically significant arrhythmia (at 12 months: 23.6% vs 4.8% with 19 vs 7 deaths, hazard ratio (HR) ¼ 5.5, 95% confidence interval (CI) 2.3 to 13.0, p < 0.0001). Excluding 7 deaths during ELR monitoring, HR ¼ 4.5, p < 0.001. Conclusion: ELR applied in patients with acute MI and LV dysfunction at the time of discharge identifies patients with high mortality risk.

2.
Indian Heart J ; 2007 Jul-Aug; 59(4): 336-41
Article Dans Anglais | IMSEAR | ID: sea-4204

Résumé

AIMS AND OBJECTIVES: Idiopathic Pulmonary Arterial Hypertension (IPAH) is a serious disorder of unknown etiology with limited therapeutic options. Sildenafil has been shown to decrease symptoms, improve hemodynamics and quality of life. Its impact on survival is uncertain. We studied the efficacy of sildenafil in improving survival in patients with IPAH. METHODS AND RESULTS: Data on survival of patients with IPAH was collected from prospectively maintained registry at our hospital from January 1999 to December 2005. Thirty nine patients who were treated with conventional therapy including digoxin, diuretics, anticoagulants and calcium channel blockers prior to January 2001 served as historical controls (control group). One hundred and thirty nine patients received sildenafil additionally from January 2001 (sildenafil group). All patients in sildenafil group showed improvement in symptoms. Survival of patients in sildenafil group was significantly better compared to historical controls receiving only conventional therapy. It was 89%, 43% and 19% in the control group Vs 93%, 75% and 54% in the sildenafil group at the end of 1, 3 and 5 years respectively (P Value=0.0002). Sildenafil was well tolerated and none of the patients had to discontinue the treatment. CONCLUSION: Sildenafil when added to conventional therapy improves symptoms as well as survival significantly compared to conventional therapy alone. Further randomized controlled trials are needed to evaluate its impact on survival when used either alone or in combination with other drugs.


Sujets)
Adolescent , Adulte , Sujet âgé , Études cas-témoins , Enfant , Enfant d'âge préscolaire , Femelle , Humains , Hypertension pulmonaire/traitement médicamenteux , Mâle , Adulte d'âge moyen , Inhibiteurs de la phosphodiestérase/usage thérapeutique , Pipérazines/usage thérapeutique , Études prospectives , Purines/usage thérapeutique , Enregistrements , Sulfones/usage thérapeutique , Analyse de survie , Résultat thérapeutique
5.
Indian Heart J ; 2005 Jul-Aug; 57(4): 339-42
Article Dans Anglais | IMSEAR | ID: sea-3913

Résumé

This report illustrates the case of a young lady evaluated for drug-refractory symptomatic paroxysmal atrial fibrillation. Successful isolation of left inferior pulmonary vein was achieved by segmental ostial ablation and circumferential Lasso mapping catheter. Patient is now free of symptoms and is off all anti-arrhythmic drugs.


Sujets)
Adulte , Fibrillation auriculaire/étiologie , Ablation par cathéter , Techniques électrophysiologiques cardiaques , Femelle , Humains , Veines pulmonaires , Récidive , Tachycardie/complications
7.
Indian Heart J ; 2003 May-Jun; 55(3): 259-61
Article Dans Anglais | IMSEAR | ID: sea-3257

Résumé

The congenital form of His bundle tachycardia is an uncommon pediatric arrhythmia. We report the case of a 7-year-old child with tachycardiomyopathy. The incessant arrhythmia, detected in infancy, was resistant to amiodarone and beta-blockers. During electrophysiologic study, the tachycardia converted to sinus rhythm with intravenous adenosine and diltiazem. Subsequently, the child is maintaining sinus rhythm on oral verapamil. Calcium-channel blockers should be considered for the treatment of this arrhythmia, which is often resistant to multiple antiarrhythmic drugs.


Sujets)
Adénosine/usage thérapeutique , Antiarythmiques/usage thérapeutique , Faisceau de His/malformations , Inhibiteurs des canaux calciques/usage thérapeutique , Enfant , Diltiazem/usage thérapeutique , Résistance aux substances/effets des médicaments et des substances chimiques , Électrocardiographie , Femelle , Humains , Métoprolol/usage thérapeutique , Tachycardie ventriculaire/diagnostic , Dysfonction ventriculaire gauche/diagnostic
8.
J Indian Med Assoc ; 2003 Feb; 101(2): 75-6, 78-80
Article Dans Anglais | IMSEAR | ID: sea-101007

Résumé

Supraventricular tachycardias (SVTs) present as recurrent palpitations. Unlike ventricular tachycardias, these arrhythmias usually carry a benign prognosis. It is important to exclude structural heart disease in these patients. Though vagal manoeuvres and drug therapy are useful for acute termination of SVTs, recurrences are common. Catheter ablation is safe, highly effective and has a curative potential. It obviates the need for long-term medical therapy as it eliminates the arrhythmia in these patients.


Sujets)
Antagonistes bêta-adrénergiques/usage thérapeutique , Antiarythmiques/usage thérapeutique , Inhibiteurs des canaux calciques/usage thérapeutique , Ablation par cathéter , Diagnostic différentiel , Humains , Inde/épidémiologie , Récidive , Tachycardie supraventriculaire/diagnostic
9.
Indian Heart J ; 2002 Jul-Aug; 54(4): 410-4
Article Dans Anglais | IMSEAR | ID: sea-5428

Résumé

BACKGROUND: Primary pulmonary hypertension is a disorder with limited treatment options and poor outcome. Sildenafil, a pulmonary vasodilator, is likely to be beneficial in primary pulmonary hypertension. We studied the clinical efficacy of sildenafil in patients with primary pulmonary hypertension. METHODS AND RESULTS: A registry of patients with primary pulmonary hypertension has been maintained in our hospital since January 1999. Of a total of 60 patients. 29 (M:16, F:13) consented to try sildenafiL. New York Heart Association functional class, six-minute walk test and Doppler echocardiographic evaluation of pulmonary artery pressure was done before and after treatment with sildenafil. Sildenafil was initiated at a dose of 25 mg thrice a day and increased up to 100 mg thrice a day as tolerated. There was a significant improvement in the functional class. The six-minute walked distance increased from 297.07+/-130.69 m at baseline to 427.68+/-85.35 m after 3 months of sildenafil therapy (p<0.0003). The mean of the pulmonary artery systolic pressure before starting sildenaffil was 109.26+/-24.15 mmHg (mean+/-SD) and it decreased to 95.15+/-24.64 mmHg (p<0.008). While 19 of the 31 historical controls in whom sildenafil was not given died during follow-up (11-44 months), only 1 of the 29 patients given sildenafil died (in an accident) during follow-up (5-20 months). CONCLUSIONS: Sildenafil, a pulmonary vasodilator, has a beneficial effect in patients with primary pulmonary hypertension in improving the functional class, six-minute walked distance and in decreasing the pulmonary artery pressures.


Sujets)
Adolescent , Adulte , Enfant , Enfant d'âge préscolaire , Femelle , Humains , Hypertension pulmonaire/traitement médicamenteux , Mâle , Adulte d'âge moyen , Pipérazines/usage thérapeutique , Études prospectives , Purines , Statistique non paramétrique , Sulfones , Analyse de survie , Vasodilatateurs/usage thérapeutique
10.
Indian Heart J ; 2001 Mar-Apr; 53(2): 203-5
Article Dans Anglais | IMSEAR | ID: sea-3979

Résumé

A one-year-old child with a structurally normal heart presented with monomorphic ventricular tachycardia. Electrocardiogram in sinus rhythm showed right bundle branch block with ST segment elevation suggesting a diagnosis of Brugada syndrome. At a later date, when the ST segment was isoelectric. intravenous procainamide caused ST elevation typical of Brugada syndrome.


Sujets)
Bloc de branche/diagnostic , Diagnostic différentiel , Électrocardiographie , Femelle , Humains , Nourrisson , Procaïnamide/diagnostic , Syncope/diagnostic , Syndrome , Tachycardie ventriculaire/diagnostic
11.
Article Dans Anglais | IMSEAR | ID: sea-94345

Résumé

A case of polymyositis associated with Bancroftian filariasis in an adult male who presented with generalised painful swelling and weakness of muscles is presented. He had elevated muscle enzymes, a myopathic EMG pattern, focal vasculitis on gastrocnemius muscle biopsy and W. bancrofti in the peripheral blood. There was clinical, biochemical and histopathological evidence of resolution of the disorder and total clearance of microfilaremia with diethyl carbamazine (DEC) therapy.


Sujets)
Maladie aigüe , Animaux , Filariose lymphatique/parasitologie , Humains , Mâle , Adulte d'âge moyen , Polymyosite/parasitologie , Wuchereria bancrofti
12.
Indian Heart J ; 1992 Mar-Apr; 44(2): 119-21
Article Dans Anglais | IMSEAR | ID: sea-4764
13.
Article Dans Anglais | IMSEAR | ID: sea-87472

Résumé

An outbreak of epidemic dropsy in Andhra Pradesh was studied during August to September 1987. Thirty cases from 6 families were identified and examined. Ghee and one oil sample were found to be contaminated with the toxic compound sanguinarine. The affected families had purchased ghee from one vendor. The epidemic ended after alerting the villagers of the contaminated ghee, and stopping its further use.


Sujets)
Alcaloïdes/intoxication , Benzophénanthridines , Matières grasses alimentaires/intoxication , Épidémies de maladies , Oedème/épidémiologie , Femelle , Contamination des aliments , Humains , Inde/épidémiologie , Isoquinoléines , Mâle
15.
Article Dans Anglais | IMSEAR | ID: sea-92022

Résumé

We report a young male with sickle cell trait who developed severe hypertension and splenic infarction soon after travel to a high altitude. Hypertension persisted for three days after a diagnostic laparotomy. His blood pressure then continued to be normal over the next one and a half years. Red cell sludging in the small vessels of the kidney possibly activated the renin angiotensin system.


Sujets)
Adulte , Mal de l'altitude/étiologie , Drépanocytose/complications , Humains , Hypertension artérielle/étiologie , Mâle , Trait drépanocytaire/complications , Infarctus splénique/étiologie
SÉLECTION CITATIONS
Détails de la recherche